211
Participants
Start Date
February 28, 2001
Primary Completion Date
April 30, 2004
Study Completion Date
February 10, 2009
dexamethasone
ondansetron
quality-of-life assessment
Cross Cancer Institute, Edmonton
British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna
Fraser Valley Cancer Centre at British Columbia Cancer Agency, Surrey
British Columbia Cancer Agency, Vancouver
Nova Scotia Cancer Centre, Halifax
Cancer Care Ontario-London Regional Cancer Centre, London
Northwestern Ontario Regional Cancer Care, Thunder Bay
Toronto Sunnybrook Regional Cancer Centre, Toronto
Princess Margaret Hospital, Toronto
CHUS-Hopital Fleurimont, Fleurimont
Maisonneuve-Rosemont Hospital, Montreal
McGill University, Montreal
Centre Hospitalier de l'Universite de Montreal, Montreal
Centre Hospitalier Universitaire de Quebec, Québec
Lead Sponsor
NCIC Clinical Trials Group
NETWORK